Loading clinical trials...
Loading clinical trials...
The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mayo Clinic
NCT06854640 · Sepsis, Coagulopathy
NCT07460349 · Early Onset Sepsis
NCT05993390 · Neuromuscular Blockade, Critical Illness, and more
NCT05218083 · COVID-19, Critical Illness, and more
NCT04886284 · Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, and more
UF Health Shands
Gainesville, Florida
Mayo Clinic
Rochester, Minnesota
Royal Brisbane and Women's Hospital
Herston, Queensland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions